FibroGen is a research-based biotechnology company using its expertise in connective tissue growth factor (CTGF) and hypoxia-inducible factor (HIF) biology to discover, develop, and commercialize novel therapeutics for serious unmet medical needs.The staff at FibroGen come from unusually diverse demographic backgrounds. The company is 44.1% female and 57.6% ethnic minorities. Despite its diversity in other areas, FibroGen employees are noticeably lacking in political diversity. It has an unusually high proportion of employees who are members of the Democratic Party, at 93.0%. Employees seem to enjoy working in an otherwise diverse workplace that is dominated by members of the Democratic Party. FibroGen has great employee retention with staff members usually staying with the company for 3.2 years.The average employee at FibroGen makes $82,290 per year. Pay at FibroGen is significantly lower than some of its highest paying competitors, like Exelixis, Gilead Sciences, and Genentech, which pay $108,978, $99,828, and $97,473, respectively.FibroGen is a medium health care company with 461 employees and an annual revenue of $140.0M that is headquartered in San Francisco, CA.
FibroGen's Mission Statement
To improve the lives of people globally by developing innovative therapies anchored in high-quality science and our passion for patients.
The founders of FibroGen are Thomas Neff and Stephen Freke.
The key people at FibroGen are Enrique A. Conterno, Thomas Neff and Stephen Freke.
Key People
Enrique A. Conterno
Thomas Neff
Stephen Freke
The Inside Scoop
FibroGen is a leading biopharmaceutical company discovering and developing a pipeline of first-in-class therapeutics. The company discovers, develops, and commercializes novel therapeutics that stop fibrosis, anemia, cancer or pathological scarring. FibroGen is headquartered in San Francisco, with subsidiary offices in Beijing and Shanghai. Their most advanced therapeutic Roxadustat is used for the treatment of anemia in chronic kidney disease, and Pamrevlumab is currently being developed for the treatment of idiopathic pulmonary fibrosis. The company was established in 1993 is San Francisco, CA.
FibroGen Rankings
FibroGen is ranked #63 on the Best Health Care Companies to Work For in America list. Zippia's Best Places to Work lists provide unbiased, data-based evaluations of companies. Rankings are based on government and proprietary data on salaries, company financial health, and employee diversity.
The average a FibroGen salary in the United States is $82,290 per year.
FibroGen employees in the top 10 percent can make over $147,000 per year,
while FibroGen employees at the bottom 10 percent earn less than $45,000 per year.
Average FibroGen Salary
$82,290
yearly
$39.56 hourly
Updated March 14, 2024
Rate the fairness of FibroGen's compensation policies.
FibroGen diversity
9.5
Diversity Score
We calculated FibroGen’s diversity score by measuring multiple factors, including the ethnic background, gender identity, and language skills of FibroGen’s workforce.
FibroGen diversity summary. Zippia estimates FibroGen's demographics and statistics using a database of 30 million profiles. Zippia verifies estimates with BLS, Census, and current job openings data for accuracy. We calculated FibroGen's diversity score by measuring multiple factors, including the ethnic background, gender identity, and language skills of FibroGen's workforce.
FibroGen has 461 employees.
44% of FibroGen employees are women, while 56% are men.
The most common ethnicity at FibroGen is White (42%).
26% of FibroGen employees are Asian.
21% of FibroGen employees are Hispanic or Latino.
The average employee at FibroGen makes $82,290 per year.
FibroGen employees are most likely to be members of the democratic party.
Employees at FibroGen stay with the company for 3.2 years on average.
Do you work at FibroGen?
Is FibroGen's workforce diverse and inclusive?
FibroGen Financial Performance
9.8
Performance Score
We calculated the performance score of companies by measuring multiple factors, including revenue, longevity, and stock market performance.
FibroGen currently has 140.7M in revenue. FibroGen's most recent quarter produced 44.3m (q2'2023).
FibroGen annual revenue
$257M
$205M
$154M
$103M
$51M
$0
2017
2018
2019
2020
2021
2022
Highest paying FibroGen competitors
Compare FibroGen salaries to competitors, including Exelixis, Gilead Sciences, and Genentech. Employees at Exelixis earn the highest average yearly salary of $108,978. The salaries at Gilead Sciences average $99,828 per year, and the salaries at Genentech come in at $97,473 per year.
Zippia gives an in-depth look into the details of FibroGen, including salaries, political affiliations, employee data, and more, in order to inform job seekers about FibroGen. The employee data is based on information from people who have self-reported their past or current employments at FibroGen. The data on this page is also based on data sources collected from public and open data sources on the Internet and other locations, as well as proprietary data we licensed from other companies. Sources of data may include, but are not limited to, the BLS, company filings, estimates based on those filings, H1B filings, and other public and private datasets. While we have made attempts to ensure that the information displayed are correct, Zippia is not responsible for any errors or omissions or for the results obtained from the use of this information. None of the information on this page has been provided or approved by FibroGen. The data presented on this page does not represent the view of FibroGen and its employees or that of Zippia.
FibroGen may also be known as or be related to FIBROGEN INC, FibroGen, FibroGen Inc, FibroGen, Inc. and Fibrogen, Inc.